Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Iovance Biotherapeutics Inc., 3 years.
Iovance Biotherapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 12, 2024 | Iovance Biotherapeutics Inc. | Option exercise | +50,000 | $7.45 | $372,500 |
| Nov 12, 2024 | Iovance Biotherapeutics Inc. | Open-market sale | −50,000 | $10.06 | $503,000 |
| Feb 1, 2024 | Tvardi Therapeutics Inc. | Grant or award | +13,500 | — | — |
| Feb 8, 2023 | Tvardi Therapeutics Inc. | Open-market sale | −5,488 | $0.53 | $2,909 |
Questions about Ryan D. Maynard
What boards is Ryan D. Maynard on?
Ryan D. Maynard sits on the board of Iovance Biotherapeutics Inc.
How long has Ryan D. Maynard served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.